p53 Gene Abnormalities Are Closely Related to Hepatoviral Infections and Occur at a Late Stage of Hepatocarcinogenesis

Cancer Research

Volumn 54, Issue 1, 1994, Pages 231-235

  Teramoto, Tadahisa ^a   Satonaka, Kazuhiro ^b   Kitazawa, Sohei ^b   Fujimori, Takahiro ^b   Hayashi, Kozaburo ^a   Maeda, Sakan ^b  

^a Public Health Research Institute of Kobe City   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONFORMATIONAL TRANSITION; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CODON; DNA, VIRAL; FEMALE; GENE DELETION; GENES, P53; GENOME, VIRAL; HEPACIVIRUS; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POINT MUTATION;

EID: 0028180458     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Kew, M. C. The hepatitis-B virus and hepatocellular carcinoma. Semin. Liver Dis. 1: 59–67, 1981.
2. Van Rensburg, S. J. Cook-Mozaffari, P. Van Schalkwyk, D. J. Van Der Watt, J. J. Vincent, T. J., and Purchase, I. F. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br. J. Cancer, 51: 713–726, 1985.
3. Lutwick, L. I. Relation between aflatoxins and hepatitis-B virus and hepatocellular carcinoma. Lancet, i: 755–757, 1979.
4. Yeh, F. S. Yu, M. C. Mo, C. C. Luo, S. Ton, M. J., and Henderson, B. E. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 49: 2506–2509, 1989.
5. Wang, J. Zindy, F. Chenivesse, X. Lamas, E. Henglein, B., and Brechot, C. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene, 7: 1653–1656, 1992.
6. Kekule, A. S. Lauer, U. Weiss, L. Luber, B., and Hofschneider, P. H. Hepatitis B virus transactivator HBx uses a tumor promoter signaling pathway. Nature (Lond.), 361: 742–745, 1993.
7. 1-adducted DNA. Proc. Natl. Acad. Sci. USA, 78: 5445–5449, 1981.
8. 1. Proc. Natl. Acad. Sci. USA, 80: 2695–2698, 1983.
9. Vogelstein, B., and Kinzler, K. W. p. 3 function and dysfunction. Cell, 70: 523–526, 1992.
10. Hsu, I. C. Metcalf, R. A. Sun, T. Welsh, J. A. Wang, N. J., and Harris, C. C. Mutational hot shot in the p. 3 gene in human hepatocellular carcinomas. Nature (Lond.), 350: 427–428, 1991.
11. Bressac, B. Kew, M. Wands, J. Oztruck, M. Selective G to T mutations of p. 3 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350: 429–431, 1991.
12. Puisieux, A. Lim, S. Groopman, J., and Ozturk, M. Selective targeting of p. 3 gene mutational hot spots in human cancers by etiologically defined carcinogens. Cancer Res. 51: 6185–6189, 1991.
13. 1 in nonhuman primates. Cancer Res. 52: 1044–1046, 1992.
14. 1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p. 3 gene. Cancer Res. 53: 9–11, 1993.
15. Scorsone, K. A. Zhou, Y. Z. Butel, J. S., and Slagle, B. L. p. 3 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinoma. Cancer Res. 52: 1635–1638, 1992.
16. Murakami, Y. Hayashi, K. Hirohashi, S., and Sekiya, T Aberrations of the tumor suppressor p. 3 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 57: 5520–5525, 1991.
17. Oda, T. Tsuda, H. Scarpa, A. Sakamoto, M., and Hirohashi, S. p. 3 gene mutation spectrum in hepatocellular carcinoma. Cancer Res. 52: 6358–6364, 1992.
18. Nishida, N. Fukuda, Y. Kokuryu, H. Toguchida, J. Yandell, D. W., and Ikenaga, N. Role and mutational heterogeneity of the p. 3 gene in hepatocellular carcinoma. Cancer Res. 53: 368–372, 1993.
19. Sheu, J-H. Huang, G-T., Lee, P-H. Chung, J-C., Chou, H-C., Lai, M-Y., Wang, J-T., Lee, H-S. Shih, L-N. Yang, P-N. et al. Mutation of p. 3 gene in hepatocellular carcinoma in Taiwan. Cancer Res. 52: 6908–6100, 1992.
20. Choo, Q-L. Kuo, G. Weiner, A. J. Overby, L. R. Bradley, D. W., and Houghton, M. Isolation of a cDNA clone derived from a blood born non-A, non-B, viral hepatitis genome. Science (Washington DC), 244: 359–362, 1989.
21. Kuo, G. Choo, Q-L. Alter, H. J., Gitnick, G. L. Redeker, A. G. Purcell, R. H. Miyamura, T. Diestag, J. L. Alter, M. J. Stevens, C. E. Tegtmeier, G. E. et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (Washington DC), 244: 362–364, 1989.
22. Kew, M. C. Houghton, M. Choo, Q-L., and Kuo, G. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet, 335: 873–874, 1990.
23. Lee, S-D. Lee, F-H. Wu, J-C., Hwang, S-J. Wang, S-S., and Lo, K-J. The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma. Cancer (Phila.), 69: 342–345, 1992.
24. Nishioka, K. Watanabe, J. Furuta, S. Tanaka, E. Iino, S. Suzuki, H. Tsuji, T. Yano, M. Kuo, G. Choo, Q-L. Houghton, M., and Oda, T. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer (Phila.), 67: 429–433, 1991.
25. Okamoto, H. Sugiyama, Y. Okada, S. Kurai, K. Akahane, Y. Sugai, Y. Tanaka, T. Sato, K. Tsuda, F. Miyakawa, Y., and Mayumi, M. Typing hepatitis C virus by polymerase chain reaction with type specific primers: application to clinical surveys and tracing infectious sources. J. Gen. Virol. 73: 673–679, 1992.
26. Yu, M. G. Mack, T. Hanisch, R. Peters, R. L. Henderson, B. E., and Pike, M. C. Hepatitis, alcohol consumption, cigarette smoking, and hepatocellular carcinoma in Los Angeles. Cancer Res. 43: 6077–6079, 1983.
27. Blot, W. J. Alcohol and cancer. Cancer Res. 52: 2119–2123, 1992.
28. Edmondson, H. A., and Steiner, P. E. Primary carcinoma of the Liver. A study of 100 cases among 48, 900 necropsies. Cancer (Phila.), 7: 462–503, 1954.
29. Sambrook, J. Fritsch, E. F., and Maniatis, T. Molecular cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
30. Chomczynski, J., and Sachi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform. Anal. Biochem. 162: 156–159, 1987.
31. Gerken, G. Kremsdorf, D. Capel, F. Petit, M. N. Dauguet, C. Manns, M. P. Zum Buschenfelde, K.-H.M., and Brechot, C. Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection. Virology, 183: 555–565, 1991.
32. Mashiyama, S. Murakami, Y. Yoshimoto, T. Sekiya, T., and Hayashi, K. Detection of p. 3 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction. Oncogene, 6: 1313–1318, 1991.
33. Haris, N. Brill, E. Shohat, O. Prococimer, M. Wolf, D. Arai, N., and Rotter, V. Molecular basis for heterogeneity of the p. 3 protein. Mol. Cell. Biol. 6: 4650–4656, 1986.
34. Ara, S. Lee, P. S. Y. Hansen, M. F., and Saya, H. Codon 72 polymorphism of TP53 gene. Nucleic Acids Res. 18: 4961, 1990.
35. Nigro, J. M. Baker, S. J. Presinger, A. C. Jessup, J. M. Hostetter, R. Cleary, K. Bigner, S. H. Davidson, N. Baylin, S. Devilee, P. et al. Mutations in the p. 3 gene occur in diverse human tumor types. Nature (Lond.), 342: 705–708, 1989.
36. Levine, A. J. Momand, J., and Finlay, C. A. The p. 3 tumor suppressor gene. Nature (Lond.), 351: 453–456, 1991.
37. Hollstein, M. Sidransky, D. Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49–53, 1991.
38. Rideout, W M. Coetzee, G. A. Olumi, A. F., and Jones P. A. 5-methyl cytosine as endogenous mutagen in the human LDL receptor and p. 3 genes. Science (Washington DC), 249: 1288–1290, 1990.
39. Shafritz, D. A., and Kew, H. C. Identification of integrated hepatitis B virus sequences in human hepatocellular carcinoma. Hepatology, 1: 1–8, 1981.
40. Loncarevic, I. F. Schranz, P. Zentgraf, H. Liang, X-H. Herrmann, G. Tang, Z-Y., and Schroder, C. Replication of hepatitis B virus in a hepatocellular carcinoma. Virology, 174: 158–168, 1990.
41. Sakurai, M. Wakasa, K. Monden, M. Yamada, T. Kurada, C., and Marukawa, T. Hepatocellular carcinoma in adenomatous hyperplasia of the liver. Cancer Chemother. Pharmacol. 23: 110–113, 1989.
42. Nakanuma, Y. Terada, T. Terasaki, T. Ueda, K. Nonomura, A. Kawahara, E., and Matsui, O. “Atypical adenomatous hyperplasia” in liver cirrhosis: low-grade hepatocellular carcinoma or borderline lesion? Histopathology, 17: 27–35, 1990.
43. Kenmochi, K. Sugihara, S., and Kojiro M. Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC. Liver, 7: 18–26, 1987.
44. Sakamoto, M. Hirohashi, S., and Shimosato, Y Early stages of multi step hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum. Pathol. 22: 172–178, 1991.
45. Baker, S. J. Presinger, A. C. Jessup, J. M. Paraskeva, C. Markowitz, S. Wilson, J. K. V. Hamilton, S., and Vogelstein, B. p. 3 gene mutations occur in combination with 17p allelic deletions as late events in colorectal carcinoma. Cancer Res. 50: 7717–7722, 1990.
46. Fults, D. Brockmeyer, D. Tullous, M. W. Pedone, C. A., and Cawthon, R. M. p. 3 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res. 52: 674–679, 1992.
47. Nakai, H. Misawa, S. Toguchida, J. Yandell, D. W., and Ishizaki, K. Frequent p. 3 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of chromosome 17p. Cancer Res. 52: 6588–6593, 1992.